ACALCULUS LYMPHOEOSINOPHILIC CHOLECYSTITIS ASSOCIATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY

被引：0
|
作者：
CHUNGPARK, M
KIM, B
MARMOLYA, G
KARLINS, N
WOJCIK, E
机构：
[1] CASE WESTERN RESERVE UNIV,METROHEALTH MED CTR,DEPT SURG,CLEVELAND,OH 44106
[2] CASE WESTERN RESERVE UNIV,METROHEALTH MED CTR,DEPT RADIOL,CLEVELAND,OH 44106
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 1990年 / 114卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1073 / 1075
页数：3
相关论文
共 50 条
  • [41] Interleukin-2 and lymphokine-activated killer cell therapy in patients with relapsed B-cell lymphorna treated with rituximab
    Pitini, Vincenzo
    Arrigo, Carmela
    Naro, Claudia
    Altavilla, Giuseppe
    CLINICAL CANCER RESEARCH, 2007, 13 (18) : 5497 - 5497
  • [42] ESTABLISHMENT OF MOUSE LYMPHOKINE-ACTIVATED KILLER-CELL CLONES AND THEIR PROPERTIES
    KATO, K
    SATO, N
    TANABE, T
    YAGITA, H
    AGATSUMA, T
    HASHIMOTO, Y
    JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (04): : 456 - 463
  • [43] LYMPHOKINE-ACTIVATED KILLER-CELL SUPPRESSOR FACTOR IN MALIGNANT EFFUSIONS
    PELTON, JJ
    TAYLOR, DD
    FOWLER, WC
    TAYLOR, CG
    CARP, NZ
    WEESE, JL
    ARCHIVES OF SURGERY, 1991, 126 (04) : 476 - 480
  • [44] PHENOTYPIC ANALYSIS OF HUMAN LYMPHOKINE-ACTIVATED KILLER-CELL CLONES
    LONG, EO
    BIASSONI, R
    MORETTA, A
    FERRINI, S
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 232 - 232
  • [45] MODULATION OF NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER-CELL CYTOTOXICITY BY LACTOFERRIN
    SHAU, HY
    KIM, A
    GOLUB, SH
    JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 51 (04) : 343 - 349
  • [46] POTENTIATED LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY GENERATED BY LOW-DOSE INTERLEUKIN-2 AND MISMATCHED DOUBLE-STRANDED-RNA
    HUBBELL, HR
    GIBSON, GD
    BIGLER, RD
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1992, 34 (04) : 259 - 264
  • [47] RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELL TREATMENT OF ADVANCED BLADDER-CANCER - CLINICAL-RESULTS AND IMMUNOLOGICAL EFFECTS
    HERMANN, GG
    GEERTSEN, PF
    VONDERMAASE, H
    STEVEN, K
    ANDERSEN, C
    HALD, T
    ZEUTHEN, J
    CANCER RESEARCH, 1992, 52 (03) : 726 - 733
  • [48] A PILOT PHASE-II TRIAL OF CONTINUOUS-INFUSION INTERLEUKIN-2 FOLLOWED BY LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY AND BOLUS-INFUSION INTERLEUKIN-2 IN RENAL-CANCER
    GAMBACORTIPASSERINI, C
    HANK, JA
    ALBERTINI, MR
    BORCHERT, AA
    MOORE, KH
    SCHILLER, JH
    BECHHOFER, R
    BORDEN, EC
    STORER, B
    SONDEL, PM
    JOURNAL OF IMMUNOTHERAPY, 1993, 13 (01): : 43 - 48
  • [49] GENERATION OF LYMPHOKINE-ACTIVATED KILLER (LAK) ACTIVITY INVIVO WITH RECOMBINANT INTERLEUKIN-2
    THOMPSON, JA
    CHEEVER, MA
    KERN, DE
    GREENBERG, PD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 318 - 318
  • [50] THE HEMODYNAMIC-EFFECTS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    GAYNOR, ER
    VITEK, L
    STICKLIN, L
    CREEKMORE, SP
    FERRARO, ME
    THOMAS, JX
    FISHER, SG
    FISHER, RI
    ANNALS OF INTERNAL MEDICINE, 1988, 109 (12) : 953 - 958
12345